Christian Schweiger
Fortune : 934 467 $ au 31/05/2026
Fortune : 934 467 $ au 31/05/2026
Dr. Christian Schweiger is a Chairman at Arxx Therapeutics AS, a Non-Executive Director at Shield Therapeutics Plc, a President at Tachris AG and a Professor at University of Duisburg-Essen.
He is on the Board of Directors at AOP Orphan International AG and Shield Therapeutics Plc.
Dr. Schweiger was previously employed as a Principal by Aventis Bio-Services, Inc., a Senior Director by Encysive Pharmaceuticals, Inc., a Principal by Sandoz AG, and a Principal by Thelin Hearth Products, Inc..
He also served on the board at Shield Holdings AG and Actelion Ltd. He received his doctorate degree from the University of Hamburg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SHIELD THERAPEUTICS PLC 1,09 % | 31/12/2025 | 11 651 713 ( 1,09 % ) | 934 467 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SHIELD THERAPEUTICS PLC | Fondateur | 01/01/2008 |
University of Duisburg-Essen
University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Tachris AG | President | - |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Président | 01/11/2021 |
AOP Orphan International AG | Directeur/Membre du Conseil | 01/10/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | - |
Thelin Hearth Products, Inc..
Thelin Hearth Products, Inc.. Building ProductsProducer Manufacturing Manufactures wood, pellet and gas stoves | Corporate Officer/Principal | - |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Directeur/Membre du Conseil | - |
| ACTELION | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Actelion Ltd.
Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
Aventis Bio-Services, Inc.
Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
University of Hamburg
University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Duisburg-Essen
University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thelin Hearth Products, Inc..
Thelin Hearth Products, Inc.. Building ProductsProducer Manufacturing Manufactures wood, pellet and gas stoves | Producer Manufacturing |
Shield Holdings AG
Shield Holdings AG Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharma products | Health Technology |
Shield Therapeutics Plc
Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products | Health Technology |
Tachris AG | |
AOP Orphan International AG | |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national